最近搜索：細胞培養(yǎng) 微生物學 分子生物 生物化學
首頁>>免疫學>>一抗>>抑癌蛋白EZH2抗體
抑癌蛋白EZH2抗體
  • 產(chǎn)品貨號：
    BN41864R
  • 中文名稱：
    抑癌蛋白EZH2抗體
  • 英文名稱：
    Rabbit anti-KMT6 Polyclonal antibody
  • 品牌：
    Biorigin

  • 貨號

    產(chǎn)品規(guī)格

    售價

    備注

  • BN41864R-50ul

    50ul

    ￥1486.00

    交叉反應：Human,Mouse(predicted:Rat,Chicken,Dog,Pig,Cow,Horse,Rabbit) 推薦應用：IHC-P,IHC-F,ICC,IF,Flow-Cyt,ELISA

  • BN41864R-100ul

    100ul

    ￥2360.00

    交叉反應：Human,Mouse(predicted:Rat,Chicken,Dog,Pig,Cow,Horse,Rabbit) 推薦應用：IHC-P,IHC-F,ICC,IF,Flow-Cyt,ELISA

  • BN41864R-200ul

    200ul

    ￥3490.00

    交叉反應：Human,Mouse(predicted:Rat,Chicken,Dog,Pig,Cow,Horse,Rabbit) 推薦應用：IHC-P,IHC-F,ICC,IF,Flow-Cyt,ELISA

產(chǎn)品描述

英文名稱EZH2
中文名稱抑癌蛋白EZH2抗體
別    名Enhancer of zeste homolog 2; Enx1h; MGC9169; Enhancer of zeste 2; ENX-1; ENX 1; ENX1; EZH 2; EZH2_HUMAN; Histone-lysine N-methyltransferase EZH2; KMT6A; Lysine N-methyltransferase 6; Enhancer of zeste homolog 2 (Drosophila); Enhancer of zeste, Drosophila, homolog 2; KMT 6;KMT6A; KMT6; WVS2.  
研究領(lǐng)域腫瘤  細胞生物  免疫學  神經(jīng)生物學  生長因子和激素  轉(zhuǎn)錄調(diào)節(jié)因子  激酶和磷酸酶  
抗體來源Rabbit
克隆類型Polyclonal
交叉反應Human, Mouse,  (predicted: Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, )
產(chǎn)品應用ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1ug/Test ICC=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量82kDa
細胞定位細胞核 
性    狀Liquid
濃    度1mg/ml
免 疫 原KLH conjugated synthetic peptide derived from human KMT6/EZH2:255-350/746 
亞    型IgG
純化方法affinity purified by Protein A
儲 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
PubMedPubMed
產(chǎn)品介紹This gene encodes a member of the Polycomb-group (PcG) family. PcG family members form multimeric protein complexes, which are involved in maintaining the transcriptional repressive state of genes over successive cell generations. This protein associates with the embryonic ectoderm development protein, the VAV1 oncoprotein, and the X-linked nuclear protein. This protein may play a role in the hematopoietic and central nervous systems. Multiple alternatively splcied transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Feb 2011].

Function:
Polycomb group (PcG) protein. Catalytic subunit of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene. Able to mono-, di- and trimethylate 'Lys-27' of histone H3 to form H3K27me1, H3K27me2 and H3K27me3, respectively. Compared to EZH2-containing complexes, it is more abundant in embryonic stem cells and plays a major role in forming H3K27me3, which is required for embryonic stem cell identity and proper differentiation. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1, CDKN2A and retinoic acid target genes. EZH2 can also methylate non-histone proteins such as the transcription factor GATA4.

Subunit:
Binds ATRX via the SET domain (Probable). Component of the PRC2/EED-EZH2 complex, which includes EED, EZH2, SUZ12, RBBP4 and RBBP7 and possibly AEBP2. The minimum components required for methyltransferase activity of the PRC2/EED-EZH2 complex are EED, EZH2 and SUZ12. The PRC2 complex may also interact with DNMT1, DNMT3A, DNMT3B and PHF1 via the EZH2 subunit and with SIRT1 via the SUZ12 subunit. Interacts with HDAC1 and HDAC2. Interacts with PRAME.

Subcellular Location:
Nucleus.

Tissue Specificity:
Expressed in many tissues. Overexpressed in numerous tumor types including carcinomas of the breast, colon, larynx, lymphoma and testis.

Post-translational modifications:
Phosphorylated by AKT1. Phosphorylation by AKT1 reduces methyltransferase activity. Phosphorylation at Thr-345 by CDK1 and CDK2 promotes maintenance of H3K27me3 levels at EZH2-target loci, thus leading to epigenetic gene silencing.
Sumoylated.

Similarity:
Belongs to the histone-lysine methyltransferase family. EZ subfamily.
Contains 1 CXC domain.
Contains 1 SET domain.

SWISS:
Q15910

Gene ID:
2146

Database links:

Entrez Gene: 2146 Human

Entrez Gene: 14056 Mouse

Entrez Gene: 312299 Rat

Omim: 601573 Human

SwissProt: Q15910 Human

SwissProt: Q61188 Mouse

Unigene: 444082 Human

Unigene: 246688 Mouse

Unigene: 9027 Rat



Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

    EZH2（enhancer of zeste homolog 2）是新識別的一種人類基因，是果蠅zeste基因增強子的人類同源基因，Polycomb group基因家族的重要成員之一。
    EZH2在多種腫瘤中高表達，具有促進細胞增殖，腫瘤細胞的擴散的惡性表型，EZH2在腫瘤中的作用成為研究熱門。EZHZ在前列腺癌、乳腺癌、膀朧癌、肝細胞癌、大腸癌、胃癌中高表達;局限性前列腺癌、乳腺癌、膀朧癌高表達EZH2，則臨床預后較差。因此EZH2可作為腫瘤標志物監(jiān)測腫瘤的演變。隨著PcG蛋白和TrxG蛋白復合物研究的深入，對細胞記憶機制的認識不斷提高，而擾亂細胞的轉(zhuǎn)錄記憶系統(tǒng)可導致個體發(fā)育缺陷，使正常細胞丟失自身特性而癌變。
    EZH2通過基因沉默機制改變細胞的記憶系統(tǒng)并調(diào)控轉(zhuǎn)錄，促進前腫瘤惡性形成。EZH2在腫瘤發(fā)生發(fā)展中的作用仍遠未闡明,特別是EZH2的下游基因仍不清楚,EZH2在腫瘤發(fā)生與發(fā)展的機制有待進一步研究。